Register Now
Course Information


Day 1      Day 2     

Saturday, December 3, 2022: Controversies

All times listed in Eastern Time
7:30 AM
Registration/Continental Breakfast/Exhibits
8:25 AM
Welcome and Introductions
Hubert Fernandez

Moderator: Michael Schwarzschild

8:30 AM
Convention vs. Innovation I: Digital technology will replace clinic-based care in PD
  • Agree: Ruth Schneider
  • Disagree: Lorraine Kalia
9:30 AM
Convention vs. Innovation II: Skin biopsy for synuclein inclusions will replace dopamine transporter imaging for PD diagnosis
  • Agree: Liana Rosenthal
  • Disagree: Zoltan Mari
10:30 AM
Refreshment Break/Exhibits

Moderator: Andrew Siderowf

11:00 AM
Enough vs. More: Updated consensus PD treatment algorithms improve PD care and outcomes
  • Agree: Hubert Fernandez
  • Disagree: Leslie Cloud
12:00 PM
Hope vs. Hype I: Spreading alpha synuclein explains cognitive deficits in Parkinson disease
  • Agree: Kelly Mills
  • Disagree: Abhimanyu Mahajan
1:00 PM

Moderator: Tanya Simuni

2:00 PM
Hope vs. Hype II: It is time to offer presymptomatic genetic testing for GBA and LRRK2 variants
  • Agree: Martha Nance
  • Disagree: Thomas Tropea
3:00 PM
Hope vs. Hype III: Rescue/On-demand therapies are preferable to device-assisted therapies in Parkinson disease
  • Agree: Stuart Isaacson
  • Disagree: Joohi Jimenez-Shahed
4:00 PM
4:00-6:00 PM
Welcome and networking reception

Back to top

Sunday, December 4, 2022: Updates

All times listed in Eastern Time
8:00 AM
Continental Breakfast/Exhibits

Moderator: Daniel Weintraub

8:30 AM
Genetic and environmental risk factors in PD: 2022 update
Michael Schwarzschild
9:15 AM
Do disease modification trials in PD require serious design modification?
Tanya Simuni
10:00 AM
Refreshment Break/Exhibits

Moderator: Joohi Jimenez-Shahed

10:30 AM
The most promising symptomatic therapies In PD
Andrew Siderowf
11:15 AM
Progress in behavioral and cognitive therapies in PD
Daniel Weintraub
12:00 PM

Back to top

A five-minute question and answer period is included in each speaker’s allotted time.